{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Epidural and Paravertebral Analgesia for Minimally Invasive Esophagectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Sample size calculation determined that 192 patients were needed to detect a minimally clinically important difference in QoR-40 scores."
      },
      "Participants": {
        "score": 2,
        "evidence": "Adult patients scheduled for transthoracic MIE with intrathoracic anastomosis were randomised to receive either epidural or paravertebral analgesia."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either epidural or paravertebral analgesia."
      },
      "Objective": {
        "score": 1,
        "evidence": "Paravertebral analgesia may offer a promising alternative to epidural analgesia, potentially reducing side effects and enhancing postoperative recovery in patients undergoing minimally invasive esophagectomy (MIE)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the Quality of Recovery (QoR-40) score on the third postoperative day (POD3)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was stratified per center using block randomisation, and allocation was not concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "This open-label, multicenter, randomised controlled superiority trial"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From December 2019 to June 2022, 192 patients were randomised: 94 to epidural and 98 to paravertebral analgesia."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The intention-to-treat analysis showed no significant difference in QoR-40 scores on POD3 between groups"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "mean difference: 3.7, 95% CI: \u22122.3 to 9.7; P = 0.268"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar between groups, with no significant differences in complications or mortality."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered in the Dutch Trial Register (NL8037)."
      },
      "Funding": {
        "score": 1,
        "evidence": "The trial was funded by institutional sources."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}